KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs
12 October 2022 - 10:01PM
Business Wire
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or
the “Company”), a leading medical technology company focused on
the development of innovative and easy-to-use subcutaneous (SQ)
infusion solutions, today announced the appointment of Brent
Rutland as the Company’s new Vice President of Medical Affairs. Mr.
Rutland will provide leadership in the Company’s clinical and data
generation strategies, key opinion leader engagement, assessing new
subcutaneous drug candidates for use with the Company’s products
and overseeing the medical affairs team. Additionally, Mr. Rutland
will be the clinical resource for the Company’s efforts in
regulatory submissions, failure modes and effects analysis, health
hazard evaluations, human factors design, new product development
and clinical evaluation updates.
“We are excited to bring Brent’s competence to the organization
– his background was a perfect fit. His expertise will advance
clinical evidence generation in support of our product pipeline,
provide valuable insight to our drug therapy candidates and help
develop important key opinion leader relationships,” said Linda
Tharby, President and CEO. “Brent has helped build multiple data
and clinical strategies, internal teams, and external networks in
his past. His deep industry experience and passion for the patient,
will make him an impactful contributor to the Company’s
strategy.”
Mr. Rutland’s career history spans an impressive 27 years and
includes working with Baxter Healthcare as a Senior Medical Science
Liaison and most recently with La Jolla Pharmaceutical Company as a
Senior Director, Health Outcomes. During his career he helped
launch 7 vaccines, 4 drugs and 1 device. Most notably, Brent aided
Baxter in the launch of Hylenex for SQ rehydration where he also
helped build the Medical Affairs department. He has received
several awards throughout his career, with the most recent being
the President’s Circle Award for Medical Affairs at La Jolla. Brent
holds a Bachelor of Science degree from Texas A&M University,
an MBA in Global Management from the University of Houston, and his
Master of Public Health from the University of North Carolina in
Epidemiology.
“I was immediately drawn to the opportunity to work at KORU
Medical as I saw the potential for future growth supported by
building out the medical science and the team,” said Brent Rutland,
Vice President of Medical Affairs. “Medical affairs helps fulfill
the unmet needs of the patient through the generation and delivery
of scientific evidence to various key outside stakeholders. I look
forward to developing a collaborative strategy to support the
Company’s overall goals.”
About KORU Medical
KORU Medical develops, manufactures, and commercializes
innovative and easy-to-use subcutaneous infusion solutions that
improve quality of life for patients around the world. The FREEDOM
Syringe Infusion System (the “Freedom System”) currently includes
the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision
Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™.
These devices are used for infusions administered in the home and
alternate care settings. For more information, please visit
www.korumedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221012005457/en/
Greg Chodaczek 347-620-7010 investor@korumedical.com
KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart
From Apr 2023 to Apr 2024